Skip to main content

Elekta Value Stock - Dividend - Research Selection

Elekta AB Series B

ISIN: SE0000163628, WKN: 896279

Market price date: 26.01.2022
Market price: 94,54 SEK


Elekta AB Series B Fundamental data and company key figures of the share

Annual reports in SEK
Key figures 18-09-2021
Cash flow
Net operating cash flow 2.551.000.000
Capital Expenditures -167.000.000
Free cash flow 2.384.000.000
Balance sheet
Total Equity 8.197.000.000
Liabilities & Shareholders equity 24.844.000.000
Income statement
Net income 1.254.000.000
Eps (diluted) 3,280
Diluted shares outstanding 382.083.000
Net sales/revenue 13.763.000.000

Fundamental ratios calculated on: 26-01-2022

Ratios
Key figures 26-01-2022
Cash flow
P/C 14,16
   
P/FC 15,15
Balance sheet
ROI5,05
ROE32,99
Income statement
P/E28,82
Div. Yield2,33%
P/B4,41
P/S2,63


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolEKTA-B.ST
Market Capitalization4.073.449.472,00 USD
CountrySweden
IndicesSTOXX EUROPE 600
SectorsHealth Care Supplies
Raw Data SourceIFRS in Millionen SEK
Stock Split2012-09-12,4.000000/1.000000; 2005-10-17,3.000000/1.000000
Internetwww.elekta.com


Description of the company

Elekta AB develops, manufactures and sells treatment planning systems for neurosurgery and radiation therapy, including stereotactic radiation surgery and brachytherapy. The company's installed base with more than 4,500 platforms and software is used in more than 6,000 hospitals worldwide. The company's sales are evenly distributed across the regions, with North and South America accounting for 31%; Europe, the Middle East and Africa account for 38%; and Asia Pacific contributed the rest.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.elekta.com


NEWS